Sunbird Bio
Christopher Gulka is a Principal Scientist at Sunbird Bio, leading the Glympse liquid biopsy production platform. Prior to this role, Christopher served as a Scientist at Sofregen Medical, conducting preclinical chemical characterization studies on silk-based hydrogel materials. Their research background includes enhancing malarial rapid diagnostic tests during their time as a Postdoctoral Scholar at Vanderbilt University and developing novel nano/micromaterials for malarial diagnostic platforms during their Ph.D. candidacy. As an Undergraduate Research Fellow at the University of Richmond, Christopher explored electron transfer kinetics of copper redox proteins.
Sunbird Bio
1 followers
Sunbird Bio is a leader in protein-based diagnostic tests, becoming the first company to overcome the challenge of accurately detecting and differentiating the specific proteins that aggregate, and therefore signal the presence of Alzheimer’s disease, with a simple blood draw. We are addressing the tremendous, growing need for more reliable and sensitive diagnostic tests to accelerate drug development and enhance patient care. Our pipeline of innovative, non-invasive technologies, such as our APEX technology, will empower researchers and clinicians with unparalleled insights not available from current tests.